{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:34:50Z","timestamp":1790998490519,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.breast.2022.05.008","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:33:02Z","timestamp":1654147982000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials"],"prefix":"10.1016","volume":"64","author":[{"given":"Charlotte","family":"Pfaffendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Vonthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Krockenberger-Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Dellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Uhlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dinges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"W\u00fcrschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Weinstrauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Eilf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Kazmierczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Fehlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Dunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-5416","authenticated-orcid":false,"given":"David","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2022.05.008_bib1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib3","first-page":"CD003860","article-title":"Fraction size in radiation therapy for breast conservation in early breast cancer","volume":"7","author":"Hickey","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2022.05.008_bib4","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib6","first-page":"JCO1800317","article-title":"Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation: results of a randomized, noninferiority clinical trial","author":"Shaitelman","year":"2018","journal-title":"J Clin Oncol : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.breast.2022.05.008_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2022.05.008_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.breast.2019.08.001","article-title":"Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer","volume":"48","author":"Andrade","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.breast.2022.05.008_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13014-016-0590-1","article-title":"Comparison of breast sequential and simultaneous integrated boost using the biologically effective dose volume histogram (BEDVH)","volume":"11","author":"Aly","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-9-36","article-title":"Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery","volume":"9","author":"Parijs","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib11","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"7","author":"Parijs","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13014-020-01652-x","article-title":"Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer","volume":"15","author":"Krug","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2020.12.005","volume":"109","author":"H\u00f6rner-Rieber","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.05.008_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2021.08.019","article-title":"Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial","volume":"163","author":"Forster","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2020.09.043","article-title":"Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: a randomized clinical trial of KROG 15-03","volume":"154","author":"Choi","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00066-014-0658-5","article-title":"Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01)","volume":"190","author":"Dellas","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.breast.2022.05.008_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00066-020-01689-7","article-title":"Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial","volume":"197","author":"Krug","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.breast.2022.05.008_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12032-017-1020-4","article-title":"Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer","volume":"34","author":"Cante","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2021.09.006","article-title":"Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost","volume":"164","author":"Franceschini","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-013-1560-8","article-title":"Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial","volume":"140","author":"Franco","year":"2014","journal-title":"J Cancer Res Clin"},{"key":"10.1016\/j.breast.2022.05.008_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2012.01.091","article-title":"Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer","volume":"84","author":"Freedman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.05.008_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2021.02.010","article-title":"Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: comparison with sequential boost in a randomized trial","volume":"158","author":"Hulle","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258186","article-title":"Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: a prospective study","volume":"16","author":"Saksornchai","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.breast.2022.05.008_bib24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy Oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.05.008_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijrobp.2014.03.036","article-title":"Prone breast intensity modulated radiation therapy: 5-year results","volume":"89","author":"Osa","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2022.05.008_bib26","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S0167-8140(21)06840-7","article-title":"OC-0291 IMPORT HIGH trial: dose escalated simultaneous integrated boost radiotherapy in early breast cancer","volume":"161","author":"Coles","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2022.05.008_bib27","series-title":"The incidence of breast cancer recurrence 10-32 Years after primary Diagnosis","author":"Pedersen","year":"2021"},{"key":"10.1016\/j.breast.2022.05.008_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.breast.2020.12.004","article-title":"Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: should the indications for radiotherapy be more personalized?","volume":"55","author":"Fodor","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2022.05.008_bib29","doi-asserted-by":"crossref","DOI":"10.21873\/anticanres.14957","article-title":"Hypofractionated radiotherapy with simultaneous-integrated boost after breast-conserving surgery compared to standard boost-applications using helical tomotherapy with TomoEdge","volume":"41","author":"Zwicker","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.breast.2022.05.008_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00066-021-01808-y","article-title":"Incidental axillary dose delivery to axillary lymph node levels I\u2013III by different techniques of whole-breast irradiation: a systematic literature review","volume":"197","author":"Schmitt","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.breast.2022.05.008_bib31","article-title":"Dosimetric evaluation of incidental irradiation to the axilla during whole breast radiotherapy for patients with left-sided early breast cancer in the IMRT era","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.breast.2022.05.008_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00066-020-01730-9","article-title":"Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial","volume":"197","author":"Krug","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.breast.2022.05.008_bib33","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ijrobp.2020.07.2091","article-title":"Patient reported experience with treatment modalities and safety of adjuvant breast radiotherapy - first results of the randomized HYPOSIB \u2013 study","volume":"108","author":"Dunst","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762200100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762200100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:45:55Z","timestamp":1760777155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762200100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":33,"alternative-id":["S096097762200100X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.05.008","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}